B cells from MS patients reportedly produce more IL-15 than controls, and activation of B cells through CD40 and the BCR induces IL-15 secretion that enhanced both the migratory capacity of CD8+ T cells across a model of the blood–brain barrier and CD8+ T cell cytotoxicity toward oligodentrocytes (59). This evidence concerns the gene CD8A and myeloid sarcoma.